Piloting prostate cancer patient-reported outcomesin clinical practice
| Autor: | Christine Tong, Doris Howell, Aamer Mahmud, Martin Korzeniowski, Maria Kalyvas, Michael Brundage, K. Zaza, Carey Shenfield |
|---|---|
| Rok vydání: | 2015 |
| Předmět: |
Oncology
Male medicine.medical_specialty Canada Attitude of Health Personnel Pain medicine medicine.medical_treatment Pilot Projects 03 medical and health sciences Prostate cancer 0302 clinical medicine Quality of life Internal medicine Surveys and Questionnaires medicine Humans 030212 general & internal medicine Aged Radiotherapy Sexual functioning business.industry Nursing research Prostatic Neoplasms Patient Preference Middle Aged medicine.disease Radiation therapy Clinical Practice Patient Outcome Assessment Curative treatment 030220 oncology & carcinogenesis Quality of Life business |
| Zdroj: | Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 24(5) |
| ISSN: | 1433-7339 |
| Popis: | The expanded prostate cancer index composite-26 (EPIC-26) instrument is a validated research tool used for capturing patient-reported quality-of-life outcomes related to the domains of bowel, bladder, and sexual functioning for men undergoing curative treatment for prostate cancer. The purpose of this pilot study was to explore the perceptions and experiences of clinicians with using EPIC-26 in a clinical setting for patients receiving curative radiotherapy.Ten clinicians reviewed EPIC-26 scores either before or during weekly clinical encounters with patients receiving curative radiation treatment for prostate cancer. After a period of 2 months, clinicians underwent individual semi-structured interviews where they were asked about their views on measuring patient-reported outcomes in practice, the value of EPIC-26, impressions on patient acceptability, and operational issues.There was a general willingness and acceptance by clinicians to use EPIC-26 for routine clinical practice. Clinician participants found EPIC-26 to be generally informative, and added value to the clinical encounter by providing additional information that was specific to prostate cancer patients. EPIC-26 was also felt to improve overall communication and provide additional insight into the patient experience.Our qualitative findings suggest that there may be a role for incorporating patient-reported outcome measure assessment tools like EPIC-26 routinely into clinical practice. However, further qualitative and quantitative research is required in order to assess the impact of patient-reported outcome information on communication, patient and clinician satisfaction, and how these and other related outcomes can be used for guiding treatment decision-making. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink